Form D · Pharmaceuticals
SONEXA THERAPEUTICS, INC
San Diego, CA · CIK 0001425227
Offering snapshot reported Aug 2, 2012 · SEC filing
- Reported sold
- $2M Offering amount: $2M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 1, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 2, 2012 | Initial | $1,999,995 | No comparison | 6 | SEC filing |
| Apr 3, 2012 | Initial | $1,224,992 | No comparison | 7 | SEC filing |
| Oct 17, 2011 | Initial | $999,994 | No comparison | 7 | SEC filing |
| Apr 7, 2010 | Amendment | $37,232,893 | No comparison | 7 | SEC filing |
| Jan 25, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-182161
Source: Form D, filed Aug 2, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Alexander | Director |
| Louis C. Bock | Director |
| Kim Puloma Kamdar | Director |
| Lynne Rollins | Executive |
| Eckard Weber, M.D. | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
12555 High Bluff Drive Suite 225
San Diego, CA, 92130
San Diego, CA, 92130